Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Alzheimer’s Disease
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • UZEDY: Information from Industry
  • View All
Back to top Open menu arrow
Download PDF Reprints
No sections available

The Journal of
Clinical Psychiatry

Free access
Suicide

Letter to the Editor June 1, 2001

Internet-Observed Suicide Attempts

Marc P. Janson; Edward S. Alessandrini; Sasha S. Strunjas; Hasan Shahab; Rif El-Mallakh; Steven B. Lippmann

J Clin Psychiatry 2001;62(6):478

Article Abstract

Letter to the Editor

Sir: The Internet has a powerful impact on society and psychiatry. It offers suicide prevention services and has even become a source of information about how to commit suicide. We report 2 separate cases in which threats of suicide were made somewhat indirectly and discovered over the Internet.

 

About the Authors

  • Marc P. Janson
    View full profile
  • Edward S. Alessandrini
    View full profile
  • Sasha S. Strunjas
    View full profile
  • Hasan Shahab
    View full profile
  • Rif El-Mallakh
    View full profile
  • Steven B. Lippmann
    View full profile
Download Free PDF

This PDF is free for all visitors!

Announcement: The Journal of Clinical Psychiatry launches a new podcast. Click to learn more.

Related JCP Articles

Neural Dysconnectivity and Affective Disorders: Integrating Sleep and Emotional Regulation Perspectives Triple Network Dysconnectivity and Sleep Disturbance in Young People With Suicidal Ideation: Reply to Ferruzzi et al Behind the Manuscript: Inpatient Treatment of Suicidality with Brett Jones, MD, MSc, PhD, FRCPC

Related PCC Articles

Suicidal Mental Imagery in Suicide Attempters Tetrabenazine-Induced Suicidality Comorbidities Obscure Autism Diagnosis
Cover features March 2026 issue highlighting articles on psychiatric drugs, peer interventions for perinatal depression, and metformin.

Vol 87 • 2026 • Number 1

Read the Current Issue

Original Research

Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024

Meta-Analysis

Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety

Original Research

Effect of Adjuvant Metformin on Adherence to and Persistence of Treatment With SGAs in Nondiabetic Patients

Editorial

Thank You to the JCP Community

Editorial

Psychotherapy: Integral to Clinical Psychiatry

Original Research

Trends in Benzodiazepine Prescribing to Adults in the United States

View current Issue

Related Articles

JCP
Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al
Letter to the Editor

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

July 3, 2023

Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.
Bénédicte Nobile, Philippe Courtet
JCP
Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link
Letter to the Editor

Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link

July 3, 2023

Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.
Laura Palagini, Pierre A. Geoffroy, Jean Arthur Micoulaud-Franchi, et al
JCP
Possible Suicidal Risk With Daridorexant
Letter to the Editor

Possible Suicidal Risk With Daridorexant

December 7, 2022

Instructions for use of the new anti-insomnia medication daridorexant mention cautious use in patients with history of suicidal behavior. This letter explores the factors that underlie this recommendation for...
Bénédicte Nobile, Emilie Olié, Philippe Courtet

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • THREADS
  • BLUESKY
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2026 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap